| Alpha Fetoprotein on Amniotic fluid |
AFPA |
Effective 03/11/23 |
| Arabinose |
ARBN |
Effective 23/04/23 |
| Calreticulin - CALR exon 9 variant screen |
CALR |
16/6/23: Included in ALRP (Leukaemia (Rapid Acute) DNA and RNA NGS Panel) and MPNS (Myeloproliferative Neoplasm NGS Screening Panel) |
| Cartilage Antibody |
ACA |
Effective 23/04/23 |
| Collagen Type 1 Cross-Linked N-Telopeptide - NTX |
NTX |
Effective 17/11/23 |
| Collagen (Type I, II, IV) Antibodies |
COAB |
Test no longer available. Effective 01/03/24 |
| Coxsackie IgM or Enterovirus IgM |
COXM |
Effective 26/05/23 |
| Endometrial Immune Profiling Biopsy RNA |
23RF |
Effective 01/02/24. An alternative test Decidualization Score (DS) is available from the same sample type: test code DSRF, TAT 2-3 weeks. |
| Functional Vitamin B Profile (B1, B2, B6) |
BIOF |
Effective 23/04/23 |
| Glutathione - Red Cell |
GLUR |
Effective 23/04/23 |
| Glutathione Reductase |
GRED |
Effective 23/04/23 |
| Gut Permeability Profile (With PEG 400) (Leaky Gut Test) |
GPP |
Effective 23/04/23 |
| Hair Mineral Analysis |
HMA |
Effective 23/04/23 |
| Hepcidin |
HPDN |
Effective 17/05/23 |
| Human Anti-Mouse Ab's (To Confirm Presence Of Heterophilic Ab's) |
HAMA |
Effective 23/04/23 |
| Inner Ear Antigen |
IEA |
Temporarily suspended until further notice. 27/10/23 |
| JAK2 - exon 12 sequencing (rare variants) |
JE12 |
16/6/23: Included in ALRP (Leukaemia (Rapid Acute) DNA and RNA NGS Panel) and MPNS (Myeloproliferative Neoplasm NGS Screening Panel) |
| JAK2 V617F genotyping assay |
JAK2 |
16/6/23: Included in ALRP (Leukaemia (Rapid Acute) DNA and RNA NGS Panel) and MPNS (Myeloproliferative Neoplasm NGS Screening Panel) |
| KRAS/NRAS screening assay |
MGP |
12/7/23: Included in ALRP (Leukaemia (Rapid Acute) DNA and RNA NGS Panel) and MPNS (Myeloproliferative Neoplasm NGS Screening Panel) |
| Kryptopyrroles |
KRYP |
Effective 23/04/23 |
| LDL7 Subfractions |
LDL7 |
Temporarily discontinued until further notice. Contact TDL Referrals Department for an update. Effective 16/02/24 |
| Listeria Antibodies |
LIST |
Effective 26/05/23 |
| Lutein |
LUTE |
Effective 23/04/23 |
| Lycopene |
LYCO |
Effective 23/04/23 |
| Mannose Binding Lectin |
MBL |
Effective 11/05/23 |
| Melanin (Urine) |
MELA |
Effective 23/04/23 |
| MPL exon 10 analysis |
MPL |
16/6/23: Included in ALRP (Leukaemia (Rapid Acute) DNA and RNA NGS Panel) and MPNS (Myeloproliferative Neoplasm NGS Screening Panel) |
| Niacin - Blood |
NIAC |
Effective 23/04/23 |
| NMP22 (Bladder Cancer Marker) |
NMP |
Replaced by UBC - Urinary Bladder cancer antigen 23/04/23 |
| Noonan Syndrome Prenatal Screen - PTPN11 exons 3 & 11 |
GENE |
Effective 03/11/23 |
| Novadiage Stool Parasite |
NOVA |
Temporarily suspended until further notice. 17/04/2024. |
| NPM1 mutascreen assay |
NPM |
16/6/23: Included in ALRP (Leukaemia (Rapid Acute) DNA and RNA NGS Panel) and MPNS (Myeloproliferative Neoplasm NGS Screening Panel) |
| Pethidine - Urine |
UPET |
Effective 23/04/23 |
| Poliovirus (Serotypes 1-3) Antibodies By Neutralization |
POLO |
Effective 17/05/23 |
| Small Intestinal Bacterial Overgrowth Test |
SIBO |
Effective 23/04/23 |
| T-SPOT.COVID |
TCEL |
Effective 04/12/23 |
| Vitamin D2/D3 |
D2D3 |
Effective 23/04/23 |
| Ziwig Endotest |
ENDT |
Temporarily suspended until further notice. 27/10/23 |